Radiation Therapy Market

Radiation Therapy Market (Type: External Beam Radiation Therapy and Internal Radiation Therapy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Radiation Therapy Market Outlook 2031

  • The global radiation therapy market was valued at US$ 6.3 Bn in 2021
  • The global market is projected to grow at a CAGR of 5.4% from 2022 to 2031
  • The global radiation therapy market is anticipated to reach US$ 10.6 Bn by the end of 2031

Analysts’ Viewpoint on Radiation Therapy Market Scenario

Cancer patients are at a high risk of contracting COVID-19; therefore, health care facilities and cancer centers are increasing awareness about the vaccination of patients. Companies in the global radiation therapy market have witnessed strong growth due to advancements in technology. For instance, Elekta received the CE mark approval for Elekta Unity magnetic resonance radiation system for commercial sale in Europe. Product advancements, such as new digital solutions, are driving the demand for radiation therapy. Various trends in radiation therapy, such as flash therapy, image-guided therapy, synthetic CT from MRI, and artificial intelligence used in radiotherapy, are also augmenting the global market. For instance, Accuray Incorporated received approval from the Atomic Energy Regulatory Board for its Radixact X9 System in India.

radiation therapy market

Overview of Radiation Therapy Market

Radiotherapy, also called radiation therapy, is a treatment provided to cancer patients. In this therapy, tumor cells are killed by using X-rays. External beam therapy and internal radiation therapy are the two primary types of radiotherapy. Radiotherapy depends on various factors such as type of cancer, size of the tumor, location of the tumor in the body, and other general parameters of the body.

Flash therapy is one of the key trends in radiation oncology. Furthermore, image-guided radiotherapy has become popular in the market. Emerging economies such as India, China, Brazil, and Malaysia offer numerous opportunities in the health care sector. Development of health care systems in these countries is propelling the demand for radiation therapy for cancer and radiation therapy equipment.

Technological advancements have been driving the global radiation therapy market over the last few years. Increase in R&D activities, rise in number of patients suffering from diseases such as cancer, and rapid growth of the health care sector in developed and developing economies have led to the introduction of new & technologically superior systems for treatment. This is likely to propel the global radiation therapy market in the next few years.

Request a sample to get extensive insights into the Radiation Therapy Market

Rise in Demand for Non-invasive Treatment Procedures to Drive Global Radiation Therapy Market

There has been a paradigm shift in the health care sector in terms of usage of methods to treat diseases, from those causing substantial pain to those that are minimally invasive and cause less pain.

Brachytherapy is one such painless therapy compared to X-ray therapy. Brachytherapy kills tumor cells or cancer cells without causing any harm or pain to the cancer patient. Treatments are delivered with a series of daily sessions or over a prescribed period. Rise in preference for non-invasive treatment procedures is creating lucrative opportunities for players in the global radiation therapy market.

Increase in Incidence of Cancer to Boost Global Radiation Therapy Market

The number of cancer patients is increasing rapidly across the globe. According to the WHO, cancer was the second largest cause of death globally, accounting for 10 million deaths in 2020. Cancer accounts for an estimated 9.6 million deaths (one in six deaths) globally each year. According to the American Institute of Cancer Research, around 18 million cancer cases were diagnosed across the world in 2018. Thus, increase in number of cancer patients is driving the global radiation therapy market.

Request a custom report on Radiation Therapy Market

External Beam Radiation Therapy Helps Increase Patient Outcomes

In terms of type, the global radiation therapy market has been bifurcated into external beam radiation therapy and internal radiation therapy. The external beam radiation therapy segment accounted for a large share of the global market in 2021. Increase in incidence and prevalence rates of cancer in developing and developed countries across the world, rise in technological advancements, and surge in health care spending are projected to boost the global radiation therapy market during the forecast period.

Cancer centers are making external beam radiation therapies, such as 3-D conformal radiation therapy, intensity-modulated radiation therapy (IMRT), and stereotactic radiosurgery, increasingly available to improve patient outcomes. Such therapy options are enabling health care companies to increase their R&D activities in oncology radiation therapy.

High Cancer Patient Footfall in Hospitals to Benefit Market Players

Based on end-user, the global radiation therapy has been divided into hospitals, specialty clinics, and others. The hospitals segment is projected to account for major share of the global market during the forecast period. This can be attributed to the rise in cancer patient population and growth in usage of various radiation therapies in hospitals. Surgeons are increasingly adopting intraoperative radiation therapy (IORT) in hospitals, since IORT facilitates higher effective doses of radiation as compared to the conventional radiation therapy.

Regional Outlook of Global Radiation Therapy Market

North America is projected to account for substantial share of the global radiation therapy market from 2022 to 2031. Increase in incidence of cancer, new product approvals, rise in mergers & acquisitions, and surge in health care expenditure are anticipated to augment the radiation therapy market in the region during the forecast period. According to the CDC, the total number of new cases of cancer in the U.S. is likely to increase by 24% in men and nearly 21% in women every year.

Rise in research & development activities, availability of more efficient & precise treatments for cancer, and collaborations among manufacturers are anticipated to drive the market in Europe during the forecast period. The market in Germany is expected to advance at a high CAGR from 2022 to 2031. This is evident as health care providers are paying more attention to radiotherapy patient positioning, as this technique helps give a patient more radiation in fewer sessions, thus saving upon time and money.

Rise in number of local players and presence of rapidly developing countries such as India are likely to augment the market in Asia Pacific. Increase in launch of new products by manufacturers is also projected to drive the radiation therapy market in Asia Pacific in the next few years.

Analysis of Key Players in Radiation Therapy Market

The global radiation therapy market is consolidated, with a small number of large players accounting for a significant share. Leading companies are making significant investments in research & development activities. Diversification of product portfolios and mergers & acquisitions are the important strategies adopted by key players. Elekta AB, Varian Medical Systems, IBA Radiopharma Solutions, Accuray Incorporated, Isoray, Inc., Mevion Medical Systems, Hitachi, Ltd., ViewRay, Inc., and Panacea Medical Technologies Pvt. Ltd. are the prominent players operating in the global radiation therapy market.

Key Developments in Global Radiation Therapy Market

  • In February 2017, ViewRay, Inc. received 510(k) clearance from the FDA to market MRIdian Linac
  • In 2018, China’s CNNR and Ion Beam Applications signed a contract for the installation of Proteus one compact proton therapy solution
  • In November 2018, Varian’s cancer treatment systems were approved in China by the National Medical Product Administration
  • In February 2019, Mevion Medical Systems, one of the leading players in the proton therapy segment, signed a contract with Allcure Kangtai Proton Technology Co., Ltd. in China. This contract was signed for the purchase of a MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning technology.
  • In March 2022, the U.S. FDA approved Novartis Pluvicto as the first targeted radioligand therapy for the treatment of progressive, PSMA positive metastatic castration-resistant prostate cancer
  • In April 2022, Elekta and GE Healthcare collaborated to increase access to precision radiation therapy solutions. This would enable the two companies to provide hospitals with a comprehensive offering across imaging & treatment for cancer patients.

Each of these players has been profiled in the radiation therapy market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Radiation Therapy Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 6.3 Bn

Market Forecast Value in 2031

US$ 10.6 Bn

Growth Rate

(CAGR)

5.4%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Mn for Value & Tons for Volume

Market Analysis

It includes cross segment analysis at global as well as regional level. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Type
    • External Beam Radiation Therapy
      • Conformal Radiation Therapy
      • Proton Beam Therapy
      • Image-guided Radiation Therapy
      • Stereotactic Radiation Therapy
      • Others
    • Internal Radiation Therapy
      • Brachytherapy
      • Systemic Radiation Therapy
  • End-user
    • Hospitals
    • Specialty Clinics
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia & CIS
  • Japan
  • China
  • India
  • ASEAN
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Elekta AB
  • Varian Medical Systems
  • IBA Radiopharma Solutions
  • Accuray Incorporated, Isoray, Inc.
  • Mevion Medical Systems
  • Hitachi, Ltd.
  • ViewRay, Inc.
  • Panacea Medical Technologies Pvt. Ltd.

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global radiation therapy market in 2021?

The global radiation therapy market was valued at US$ 6.3 Bn in 2021

How big will be the global radiation therapy market in 2031?

The global radiation therapy market is projected to reach more than US$ 10 Bn by 2031

What was the CAGR of the global radiation therapy market from 2017 to 2021?

The global radiation therapy market grew at a CAGR of 3.9% from 2017 to 2021

What will be the CAGR of the global radiation therapy market during the forecast period (2022–2031)?

The global radiation therapy market is anticipated to expand at a CAGR of 5.4% from 2022 to 2031

Which are the prominent trends that affect market growth?

Increase in incidence of cancer and rise in demand for non-invasive treatment procedures drive the global radiation therapy market

Which region is likely to account for major share of the global market during the forecast period?

North America is projected to account for major share of the global market during the forecast period

Who are the prominent players in the global radiation therapy market?

Prominent players in the global radiation therapy market include Elekta AB, Varian Medical Systems, IBA Radiopharma Solutions, Accuray Incorporated, Isoray, Inc., Mevion Medical Systems, Hitachi, Ltd., ViewRay, Inc., and Panacea Medical Technologies Pvt. Ltd.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Radiation Therapy Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Therapy Type Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Radiation Therapy Market Analysis and Forecast, 2017-2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Market Outlook

        5.1. Healthcare Industry Overview

    6. Global Radiation Therapy Market Analysis and Forecast, by Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Type, 2017-2031

            6.3.1. External Beam Radiation Therapy

                6.3.1.1. Conformal Radiation Therapy

                6.3.1.2. Proton Beam Therapy

                6.3.1.3. Image-guided Radiation Therapy

                6.3.1.4. Stereotactic Radiation Therapy

                6.3.1.5. Others

            6.3.2. Internal Radiation Therapy

                6.3.2.1. Brachytherapy

                6.3.2.2. Systemic Radiation Therapy

        6.4. Market Attractiveness Analysis, by Type

    7. Global Radiation Therapy Market Analysis and Forecast, by End-user

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by End-user, 2017-2031

            7.3.1. Hospitals

            7.3.2. Specialty Clinics

            7.3.3. Others

        7.4. Market Attractiveness Analysis, by End-user

    8. Global Radiation Therapy Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness Analysis, by Region

    9. North America Radiation Therapy Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value Forecast, by Type, 2017-2031

            9.2.1. External Beam Radiation Therapy

                9.2.1.1. Conformal Radiation Therapy

                9.2.1.2. Proton Beam Therapy

                9.2.1.3. Image-guided Radiation Therapy

                9.2.1.4. Stereotactic Radiation Therapy

                9.2.1.5. Others

            9.2.2. Internal Radiation Therapy

                9.2.2.1. Brachytherapy

                9.2.2.2. Systemic Radiation Therapy

        9.3. Market Value Forecast, by End-user, 2017-2031

            9.3.1. Hospitals

            9.3.2. Specialty Clinics

            9.3.3. Others

        9.4. Market Value Forecast, by Country, 2017-2031

            9.4.1. U.S.

            9.4.2. Canada

        9.5. Market Attractiveness Analysis

            9.5.1. By Type

            9.5.2. By End-user

            9.5.3. By Country

    10. Europe Radiation Therapy Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Type, 2017-2031

            10.2.1. External Beam Radiation Therapy

                10.2.1.1. Conformal Radiation Therapy

                10.2.1.2. Proton Beam Therapy

                10.2.1.3. Image-guided Radiation Therapy

                10.2.1.4. Stereotactic Radiation Therapy

                10.2.1.5. Others

            10.2.2. Internal Radiation Therapy

                10.2.2.1. Brachytherapy

                10.2.2.2. Systemic Radiation Therapy

        10.3. Market Value Forecast, by End-user, 2017-2031

            10.3.1. Hospitals

            10.3.2. Specialty Clinics

            10.3.3. Others

        10.4. Market Value Forecast, by Country/Sub-region, 2017-2031

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe

        10.5. Market Attractiveness Analysis

            10.5.1. By Type

            10.5.2. By End-user

            10.5.3. By Country/Sub-region

    11. Asia Pacific Radiation Therapy Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Type, 2017-2031

            11.2.1. External Beam Radiation Therapy

                11.2.1.1. Conformal Radiation Therapy

                11.2.1.2. Proton Beam Therapy

                11.2.1.3. Image-guided Radiation Therapy

                11.2.1.4. Stereotactic Radiation Therapy

                11.2.1.5. Others

            11.2.2. Internal Radiation Therapy

                11.2.2.1. Brachytherapy

                11.2.2.2. Systemic Radiation Therapy

        11.3. Market Value Forecast, by End-user, 2017-2031

            11.3.1. Hospitals

            11.3.2. Specialty Clinics

            11.3.3. Others

        11.4. Market Value Forecast, by Country/Sub-region, 2017-2031

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Market Attractiveness Analysis

            11.5.1. By Type

            11.5.2. By End-user

            11.5.3. By Country/Sub-region

    12. Latin America Radiation Therapy Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Type, 2017-2031

            12.2.1. External Beam Radiation Therapy

                12.2.1.1. Conformal Radiation Therapy

                12.2.1.2. Proton Beam Therapy

                12.2.1.3. Image-guided Radiation Therapy

                12.2.1.4. Stereotactic Radiation Therapy

                12.2.1.5. Others

            12.2.2. Internal Radiation Therapy

                12.2.2.1. Brachytherapy

                12.2.2.2. Systemic Radiation Therapy

        12.3. Market Value Forecast, by End-user, 2017-2031

            12.3.1. Hospitals

            12.3.2. Specialty Clinics

            12.3.3. Others

        12.4. Market Value Forecast, by Country/Sub-region, 2017-2031

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Market Attractiveness Analysis

            12.5.1. By Type

            12.5.2. By End-user

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Radiation Therapy Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Type, 2017-2031

            13.2.1. External Beam Radiation Therapy

                13.2.1.1. Conformal Radiation Therapy

                13.2.1.2. Proton Beam Therapy

                13.2.1.3. Image-guided Radiation Therapy

                13.2.1.4. Stereotactic Radiation Therapy

                13.2.1.5. Others

            13.2.2. Internal Radiation Therapy

                13.2.2.1. Brachytherapy

                13.2.2.2. Systemic Radiation Therapy

        13.3. Market Value Forecast, by End-user, 2017-2031

            13.3.1. Hospitals

            13.3.2. Specialty Clinics

            13.3.3. Others

        13.4. Market Value Forecast, by Country/Sub-region, 2017-2031

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Market Attractiveness Analysis

            13.5.1. By Type

            13.5.2. By End-user

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (by tier and size of companies)

        14.2. Market Share Analysis, by Company, 2021

        14.3. Company Profiles

            14.3.1. Elekta AB

                14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.1.2. Financial Overview

                14.3.1.3. Product Portfolio

                14.3.1.4. SWOT Analysis

                14.3.1.5. Strategic Overview

            14.3.2. Varian Medical Systems

                14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.2.2. Financial Overview

                14.3.2.3. Product Portfolio

                14.3.2.4. SWOT Analysis

                14.3.2.5. Strategic Overview

            14.3.3. IBA Radiopharma Solutions

                14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.3.2. Financial Overview

                14.3.3.3. Product Portfolio

                14.3.3.4. SWOT Analysis

                14.3.3.5. Strategic Overview

            14.3.4. Accuray Incorporated

                14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.4.2. Financial Overview

                14.3.4.3. Product Portfolio

                14.3.4.4. SWOT Analysis

                14.3.4.5. Strategic Overview

            14.3.5. Isoray, Inc.

                14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.5.2. Financial Overview

                14.3.5.3. Product Portfolio

                14.3.5.4. SWOT Analysis

                14.3.5.5. Strategic Overview

            14.3.6. Mevion Medical Systems

                14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.6.2. Financial Overview

                14.3.6.3. Product Portfolio

                14.3.6.4. SWOT Analysis

                14.3.6.5. Strategic Overview

            14.3.7. Hitachi, Ltd.

                14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.7.2. Financial Overview

                14.3.7.3. Product Portfolio

                14.3.7.4. SWOT Analysis

                14.3.7.5. Strategic Overview

            14.3.8. ViewRay, Inc.

                14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.8.2. Financial Overview

                14.3.8.3. Product Portfolio

                14.3.8.4. SWOT Analysis

                14.3.8.5. Strategic Overview

            14.3.9. Panacea Medical Technologies Pvt. Ltd.

                14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.9.2. Financial Overview

                14.3.9.3. Product Portfolio

                14.3.9.4. SWOT Analysis

                14.3.9.5. Strategic Overview

    List of Tables

    Table 01: Global Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031

    Table 02: Global Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031

    Table 03: Global Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031

    Table 04: Global Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 05: Global Radiation Therapy Market Size (US$ Mn) Forecast, by Region, 2017-2031

    Table 06: North America Radiation Therapy Market Size Value (US$ Mn) Forecast, by Country, 2016–2018

    Table 07: North America Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031

    Table 08: North America Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031

    Table 09: North America Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031

    Table 10: North America Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 11: Europe Radiation Therapy Market Size Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 12: Europe Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031

    Table 13: Europe Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031

    Table 14: Europe Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031

    Table 15: Europe Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 16: Asia Pacific Radiation Therapy Market Size Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 17: Asia Pacific Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031

    Table 18: Asia Pacific Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031

    Table 19: Asia Pacific Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031

    Table 20: Asia Pacific Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 21: Latin America Radiation Therapy Market Size Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 22: Latin America Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031

    Table 23: Latin America Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031

    Table 24: Latin America Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031

    Table 25: Latin America Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 26: Middle East & Africa Radiation Therapy Market Size Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 27: Middle East & Africa Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031

    Table 28: Middle East & Africa Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031

    Table 29: Middle East & Africa Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031

    Table 30: Middle East & Africa Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    List of Figures

    Figure 01: Global Radiation Therapy Market Size Value (US$ Mn) Forecast, 2017-2031

    Figure 02: Global Radiation Therapy Market Value Share (%), by Type, 2017

    Figure 03: Global Radiation Therapy Market Value Share (%), by End user, 2017

    Figure 04: Global Radiation Therapy Market Value Share (%), by Region, 2017

    Figure 05: Global Radiation Therapy Market Value Share (%), by External Beam Radiation Therapy, 2017

    Figure 06: Global Radiation Therapy Market Value Share (%), by Internal Radiation Therapy, 2017

    Figure 07: Global Radiation Therapy Market Value Share (%), by Type, 2018 and 2026

    Figure 08: Global Radiation Therapy Market Attractiveness Analysis, by Type, 2018–2026

    Figure 09: Global Radiation Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by External Beam Radiation Therapy, 2017-2031

    Figure 10: Global Radiation Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Internal Radiation Therapy, 2017-2031

    Figure 11: Global Radiation Therapy Market Value Share Analysis, by End-user, 2018–2026

    Figure 12: Global Radiation Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2031

    Figure 13: Global Radiation Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017-2031

    Figure 14: Global Radiation Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031

    Figure 15: Global Radiation Therapy Market Attractiveness Analysis, by End-user, 2018–2026

    Figure 16: Global Radiation Therapy Market Value Share Analysis, by Region, 2018 and 2026

    Figure 17: Global Radiation Therapy Market Attractiveness Analysis, by Region, 2018–2026

    Figure 18: North America Radiation Therapy Market Size (US$ Mn) Forecast, 2017-2031

    Figure 19: North America Radiation Therapy Market Value Share Analysis, by Country, 2018 and 2026

    Figure 20: North America Radiation Therapy Market Attractiveness Analysis, by Country, 2018–2026

    Figure 21: North America Radiation Therapy Market Value Share (%), by Type, 2018 and 2026

    Figure 22: North America Radiation Therapy Market Attractiveness Analysis, by Type, 2018–2026

    Figure 23: North America Radiation Therapy Market Value Share Analysis, by End-user, 2018–2026

    Figure 24: North America Radiation Therapy Market Attractiveness Analysis, by End-user, 2018–2026

    Figure 25: Europe Radiation Therapy Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031

    Figure 26: Europe Radiation Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2026

    Figure 27: Europe Radiation Therapy Market Attractiveness Analysis, by Country/Sub-region, 2018–2026

    Figure 28: Europe Radiation Therapy Market Value Share (%), by Type, 2018 and 2026

    Figure 29: Europe Radiation Therapy Market Attractiveness Analysis, by Type, 2018–2026

    Figure 30: Europe Radiation Therapy Market Value Share Analysis, by End-user, 2018–2026

    Figure 31: Europe Radiation Therapy Market Attractiveness Analysis, by End-user, 2018–2026

    Figure 32: Asia Pacific Radiation Therapy Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031

    Figure 33: Asia Pacific Radiation Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2026

    Figure 34: Asia Pacific Radiation Therapy Market Attractiveness Analysis, by Country/Sub-region, 2018–2026

    Figure 35: Asia Pacific Radiation Therapy Market Value Share (%), by Type, 2018 and 2026

    Figure 36: Asia Pacific Radiation Therapy Market Attractiveness Analysis, by Type, 2018–2026

    Figure 37: Asia Pacific Radiation Therapy Market Value Share Analysis, by End-user, 2018–2026

    Figure 38: Asia Pacific Radiation Therapy Market Attractiveness Analysis, by End-user, 2018–2026

    Figure 39: Latin America Radiation Therapy Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031

    Figure 40: Latin America Radiation Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2026

    Figure 41: Latin America Radiation Therapy Market Attractiveness Analysis, by Country/Sub-region, 2018–2026

    Figure 42: Latin America Radiation Therapy Market Value Share (%), by Type, 2018 and 2026

    Figure 43: Latin America Radiation Therapy Market Attractiveness Analysis, by Type, 2018–2026

    Figure 44: Latin America Radiation Therapy Market Value Share Analysis, by End-user, 2018–2026

    Figure 45: Latin America Radiation Therapy Market Attractiveness Analysis, by End-user, 2018–2026

    Figure 46: Middle East & Africa Radiation Therapy Market Size (US$ Mn) Forecast, 2017-2031

    Figure 47: Middle East & Africa Radiation Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2026

    Figure 48: Middle East & Africa Radiation Therapy Market Attractiveness Analysis, by Country/Sub-region, 2018–2026

    Figure 49: Middle East & Africa Radiation Therapy Market Value Share (%), by Type, 2018 and 2026

    Figure 50: Middle East & Africa Radiation Therapy Market Attractiveness Analysis, by Type, 2018–2026

    Figure 51: Middle East & Africa Radiation Therapy Market Value Share Analysis, by End-user, 2018–2026

    Figure 52: Middle East & Africa Radiation Therapy Market Attractiveness Analysis, by End-user, 2018–2026

    Figure 53: Global Radiation Therapy Market Share, by Company, 2017

    Figure 54: Elekta AB Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

    Figure 55: Elekta AB Breakdown of Net Sales, by Region/Sub-Region, 2017/2018

    Figure 56: Elekta AB Breakdown of Research & Development Expenses (US$ Mn), 2016–2018

    Figure 57: Varian Medical Systems Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018

    Figure 58: Varian Medical Systems Breakdown of Net Sales, by Region, 2017

    Figure 59: Varian Medical Systems Breakdown of Net Sales, by Business Segment, 2017/2018

    Figure 60: Varian Medical Systems Research & Development Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018

    Figure 61: IBA Radiopharma Solutions Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018

    Figure 62: IBA Radiopharma Solutions Breakdown of Net Sales, by Therapy, 2018

    Figure 63: IBA Radiopharma Solutions R & D Investments (US$ Mn) & Y-o-Y Growth (%), 2016–2018

    Figure 64: Accuray Incorporated Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018

    Figure 65: Accuray Incorporated Breakdown of Net Sales, by Region, 2018

    Figure 66: Accuray Incorporated R&D Investments (US$ Mn) & Y-o-Y Growth (%), 2016–2018

    Figure 67: Accuray Incorporated Breakdown of Net Sales, by Business Segment, 2018

    Figure 68: Isoray, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 69: Isoray, Inc. Breakdown of Net Sales, by Region, 2018

    Figure 70: Isoray, Inc. R&D investments (US$ Mn) and Y-o-Y Growth (%), 2017–2018

    Figure 71: Isoray, Inc. Breakdown of Net Sales, by Business Segment, 2018

    Figure 72: Hitachi, Ltd. Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2018

    Figure 73: Hitachi, Ltd. Healthcare Business Segment Breakdown of Net Sales (%), by Region, 2018

    Figure 74: Hitachi, Ltd. Healthcare Business Segment Breakdown of Net Sales (%), by Sub-segment, 2018

    Figure 75: ViewRay, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018

    Figure 76: ViewRay, Inc. Breakdown of Net Sales, by Region, 2018

    Figure 77: ViewRay, Inc. R & D Investments (US$ Mn) & Y-o-Y Growth (%), 2016–2018

    Figure 78: ViewRay, Inc. Breakdown of Net Sales, by Business Segment, 2018

Copyright © Transparency Market Research, Inc. All Rights reserved